Successful treatment of checkpoint inhibitor-associated bullous pemphigoid with dupilumab in a patient with angiosarcoma

被引：3
|
作者：
Hansen, Inga [1 ,2 ]
Gebhardt, Christoffer [1 ]
Booken, Nina [1 ]
Schneider, Stefan W. [1 ]
机构：
[1] Univ klinikum Hamburg Eppendorf, Klin Poliklin Dermatol & Venerol, Hamburg, Germany
[2] Univ klinikum Hamburg Eppendorf, Klin Dermatol & Venerol, Martinistr 52, Hamburg, 20246, Germany
来源：
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2024年 / 22卷 / 04期
关键词：
D O I：
10.1111/ddg.15340
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：587 / 589
页数：3
相关论文
共 50 条
  • [31] Omalizumab and Dupilumab for the Treatment of Bullous Pemphigoid: A Systematic Review
    Granados-Betancort, Elena
    Sanchez-Diaz, Manuel
    Munoz-Barba, Daniel
    Arias-Santiago, Salvador
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (16)
  • [32] Successful Treatment of Bullous Pemphigoid With Omalizumab
    London, Vanessa A.
    Kim, Gene H.
    Fairley, Janet A.
    Woodley, David T.
    ARCHIVES OF DERMATOLOGY, 2012, 148 (11) : 1241 - 1243
  • [33] Approach to the Patient With Immune Checkpoint Inhibitor-Associated Endocrine Dysfunction
    Wright, Jordan J.
    Johnson, Douglas B.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2023, 108 (06): : 1514 - 1525
  • [34] Successful dupilumab treatment in bullous pemphigoid complicated with subacute hematogenous disseminated tuberculosis: A case report
    Dong, Qian
    Zheng, Rui
    He, Zhe
    Xi, Yue
    SKIN RESEARCH AND TECHNOLOGY, 2024, 30 (07)
  • [35] Dipeptidyl Peptidase 4 Inhibitor-Associated Bullous Pemphigoid Is Characterized by an Altered Expression of Cytokines in the Skin
    Tuusa, Jussi
    Kokkonen, Nina
    Mattila, Anja
    Huilaja, Laura
    Varpuluoma, Outi
    Rannikko, Sirpa
    Glumoff, Virpi
    Miettunen, Jouko
    Tasanen, Kaisa
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (01) : 78 - +
  • [36] Epitope-spreading phenomena in dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid
    Garcia-Diez, I.
    Espana, A.
    Iranzo, P.
    BRITISH JOURNAL OF DERMATOLOGY, 2019, 180 (05) : 1267 - 1268
  • [37] Case of dipeptidyl peptidase 4 inhibitor-associated bullous pemphigoid that developed after a scabies infestation
    Iriki, Hisato
    Adachi, Takahiro
    Matsuda, Hideshi
    Chinen, Katsuya
    Arakawa, Hiroki
    Yamagami, Jun
    Nishie, Wataru
    Yokouchi, Mariko
    JOURNAL OF DERMATOLOGY, 2020, 47 (07): : E258 - E260
  • [38] Clinical and immunological profile of patients with dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid
    Bellinato, Francesco
    Maurelli, Martina
    Schena, Donatella
    Gisondi, Paolo
    Girolomoni, Giampiero
    ITALIAN JOURNAL OF DERMATOLOGY AND VENEREOLOGY, 2021, 156 (04) : 455 - 459
  • [39] Antibiotic exposure for immune checkpoint inhibitor induced bullous pemphigoid associated with worse outcomes
    Fay, C. J.
    Awh, K.
    Said, J. T.
    Allais, B. S.
    LeBoeuf, N.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (05) : S95 - S95
  • [40] Immune checkpoint inhibitor-associated nephritis-treatment standard
    Barbir, Elena-Bianca
    Kitchlu, Abhijat
    Herrmann, Sandra M.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 (11) : 1785 - 1798
12345